Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5186617
Max Phase: Preclinical
Molecular Formula: C31H40N10O7
Molecular Weight: 664.72
Associated Items:
ID: ALA5186617
Max Phase: Preclinical
Molecular Formula: C31H40N10O7
Molecular Weight: 664.72
Associated Items:
Canonical SMILES: COC(=O)c1cc(O)c2cc(NC(=O)NCCCCCCCNC(=N)NC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2c1
Standard InChI: InChI=1S/C31H40N10O7/c1-47-29(45)18-11-17-7-8-19(13-20(17)21(42)12-18)40-31(46)35-10-6-4-2-3-5-9-34-30(33)36-14-22-24(43)25(44)28(48-22)41-16-39-23-26(32)37-15-38-27(23)41/h7-8,11-13,15-16,22,24-25,28,42-44H,2-6,9-10,14H2,1H3,(H2,32,37,38)(H3,33,34,36)(H2,35,40,46)/t22-,24-,25-,28-/m1/s1
Standard InChI Key: GZLKEWKXXDOJMT-ZYWWQZICSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 664.72 | Molecular Weight (Monoisotopic): 664.3081 | AlogP: 1.56 | #Rotatable Bonds: 13 |
Polar Surface Area: 254.88 | Molecular Species: BASE | HBA: 13 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.68 | CX Basic pKa: 11.88 | CX LogP: 0.99 | CX LogD: -0.24 |
Aromatic Rings: 4 | Heavy Atoms: 48 | QED Weighted: 0.04 | Np Likeness Score: 0.13 |
1. Iannelli G, Milite C, Marechal N, Cura V, Bonnefond L, Troffer-Charlier N, Feoli A, Rescigno D, Wang Y, Cipriano A, Viviano M, Bedford MT, Cavarelli J, Castellano S, Sbardella G.. (2022) Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach., 65 (17.0): [PMID:35482954] [10.1021/acs.jmedchem.2c00252] |
Source(1):